Rosenfeld P J, Flynn H W, McDonald H R, Rubsamen P E, Smiddy W E, Sipperley J O, Boniuk I, Packer A J
Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, School of Medicine, FL, USA.
Ophthalmic Surg Lasers. 1998 Mar;29(3):190-7.
To assess the outcomes of vitreoretinal surgery in the treatment of vision-threatening posterior segment complications of X-linked retinoschisis.
The authors performed a retrospective analysis of 16 eyes from 11 patients who underwent vitreoretinal surgery. All the patients had a documented positive family history of X-linked retinoschisis, and all patients had bilateral macular disease.
The ages of the patients ranged from 14 months to 37 years (mean age 15.1 years; median age 11.5 years), and postoperative follow-up ranged from 3 months to 10 years (mean 2.8 years; median 1 year). The indications for surgical intervention included rhegmatogenous retinal detachment (12 eyes), vitreous hemorrhage (2 eyes), progression of the schisis cavity through the fovea (2 eyes), cataract associated with a persistent hyperplastic primary vitreous-like condition (2 eyes), and exudative maculopathy (1 eye). The primary surgical intervention included pars plana vitrectomy alone (7 eyes), pars plana vitrectomy and pars plana lensectomy (4 eyes), and a scleral buckle procedure alone (5 eyes). Surgical success (defined as reattachment of the retina, removal of media opacities, or arrest of schisis progression) was achieved in 14 of 16 eyes, after an average of 1.2 procedures per eye. The major reason for reoperations was recurrent retinal detachment due to proliferative vitreoretinopathy. Two eyes were eventually enucleated due to pain associated with neovascular glaucoma resulting from recurrent retinal detachment. Of the remaining 14 eyes, visual acuity improved in 8 eyes and remained unchanged in 6 eyes.
Vitreoretinal surgery is often helpful in stabilizing or improving visual function in patients with posterior segment complications from X-linked retinoschisis.
评估玻璃体视网膜手术治疗X连锁视网膜劈裂症威胁视力的后段并发症的疗效。
作者对11例接受玻璃体视网膜手术的患者的16只眼进行了回顾性分析。所有患者均有记录在案的X连锁视网膜劈裂症阳性家族史,且均患有双侧黄斑疾病。
患者年龄从14个月至37岁不等(平均年龄15.1岁;中位年龄11.5岁),术后随访时间从3个月至10年不等(平均2.8年;中位1年)。手术干预的指征包括孔源性视网膜脱离(12只眼)、玻璃体积血(2只眼)、劈裂腔通过黄斑进展(2只眼)、与持续性增生性原发性玻璃体样病变相关的白内障(2只眼)以及渗出性黄斑病变(1只眼)。主要的手术干预包括单纯的平坦部玻璃体切除术(7只眼)、平坦部玻璃体切除术和平坦部晶状体切除术(4只眼)以及单纯的巩膜扣带术(5只眼)。16只眼中有14只眼获得了手术成功(定义为视网膜复位、清除介质混浊或劈裂进展停止),每只眼平均进行了1.2次手术。再次手术的主要原因是增殖性玻璃体视网膜病变导致的复发性视网膜脱离。2只眼最终因复发性视网膜脱离导致新生血管性青光眼相关疼痛而被摘除眼球。其余14只眼中,8只眼视力提高,6只眼视力保持不变。
玻璃体视网膜手术通常有助于稳定或改善X连锁视网膜劈裂症后段并发症患者的视功能。